• Leaders and advisors involved in the future of healthcare, particularly in prevention and delay of illness and aging
  • Industry, including startups, developing pharmaceutical, digital health, nutrition, new business model and other approaches to disease prevention and healthy aging
  • Scientists involved in metabolic, cancer, dementia, cardiovascular and aging-related research
  • Clinical investigators and healthcare providers involved in chronic non-communicable disease care and prevention
  • Government regulators and policy makers
  • Funders, payers and investors (including capital markets, philanthropies, government and insurers) in disease prevention and healthy aging
  • Federal and local health organization executives
  • Epidemiologists, social scientists, economists, bioethicists, patient advocates, journalists and others thinking about how to harness emerging science behind Metabesity for global public health